Coordinates the Janssen support to the UMURINZI program
Session: Building Clinical Trials Capacity in Africa
March 12, 2020
07:30 – 08:30
Since September 2019 assigned by Janssen Global Public Health R&D to coordinate the Janssen support to the UMURINZI program, an Ebola Vaccination Implementation Research Program to demonstrate the feasibility of a preventive vaccination approach using a heterologous two-dose vaccine regimen in Rwanda. Living and working in Rwanda. Studied Biology and worked for Johnson & Johnson Family of Companies for over 30 years, was part of drug development teams working on HIV, hepatitis, tuberculosis, and Ebola leading to highly innovative new medicines and vaccines of high medical need. Leading strategic partnerships in Global Public Health.